Global methylation profiling of lymphoblastoid cell lines reveals epigenetic contributions to autism spectrum disorders and a novel autism candidate gene, RORA , whose protein product is reduced in autistic brain
Open accessThe DOI matches its Crossref record; 67 of the 68 references it cites were found in a registry or an index.
Abstract
Autism is currently considered a multigene disorder with epigenetic influences. To investigate the contribution of DNA methylation to autism spectrum disorders, we have recently completed large‐scale methylation profiling by CpG island microarray analysis of lymphoblastoid cell lines derived from monozygotic twins discordant for diagnosis of autism and their nonautistic siblings. Methylation profiling revealed many candidate genes differentially methylated between discordant MZ twins as well as between both twins and nonautistic siblings. Bioinformatics analysis of the differentially methylated genes demonstrated enrichment for high‐level functions including gene transcription, nervous system development, cell death/survival, and other biological processes implicated in autism. The methylation status of 2 of these candidate genes, BCL‐2 and retinoic acid‐related orphan receptor alpha ( RORA ), was further confirmed by bisulfite sequencing and methylation‐specific PCR, respectively. Immunohistochemical analyses of tissue arrays containing slices of the cerebellum and frontal cortex of autistic and age‐ and sex‐matched control subjects revealed decreased expression of RORA and BCL‐2 proteins in the autistic brain. Our data thus confirm the role of epigenetic regulation of gene expression via differential DNA methylation in idiopathic autism, and furthermore link molecular changes in a peripheral cell model with brain pathobiology in autism.—Nguyen, A., Rauch, T. A., Pfeifer, G. P., Hu, V. W. Global methylation profiling of lymphoblastoid cell lines reveals epigenetic contributions to autism spectrum disorders and a novel autism candidate gene, RORA , whose protein product is reduced in autistic brain. FASEB J . 24, 3036–3051 (2010). www.fasebj.org
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“One potential pathway by which testosterone influences ASD risk may involve RORA (retinoic acid-related orphan receptor-alpha), a gene down-regulated in ASD lymphoblastoid cell lines [74].”
From Sex differences in autism spectrum disorders (2013) · cites this paper as [74]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“direct changes in DNA methylation profile in lymphoblastoid cells of autistic patients were reported recently76 showing a decreased expression of retinoic acid-related orphan receptor alpha gene (RORA) and B-cell lymphoma 2 (BCL-2)”
From Autism risk factors: genes, environment, and gene-environment interactions (2012) · cites this paper as [76]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
In silico prediction of protein-protein interactions in human macrophages
Souiai, O., Guerfali, F., Ben Miled, S., Brun, C., & Benkahla, A. (2014) · BMC Research Notes · doi:10.1186/1756-0500-7-157 · Cited by 10,803
Significance analysis of microarrays applied to the ionizing radiation response
Tusher, V. G., Tibshirani, R., & Chu, G. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.091062498 · Cited by 10,568
Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2
Amir, R. E., Van den Veyver, I. B., Wan, M., Tran, C. Q., Francke, U., & Zoghbi, H. Y. (1999) · Nature Genetics · doi:10.1038/13810 · Cited by 4,990
Genomic DNA methylation: the mark and its mediators.
Klose, R. J., & Bird, A. P. (2006) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2005.12.008 · Cited by 2,501 · cited 1×
“(24), unmethylated CpG sites can be found clustered in”
BackgroundAutism as a strongly genetic disorder: evidence from a British twin study
Bailey, A., Le Couteur, A., Gottesman, I., Bolton, P., Simonoff, E., Yuzda, E., & Rutter, M. (1995) · Psychological Medicine · doi:10.1017/s0033291700028099 · Cited by 2,461 · cited 1×
“Although autism is largely considered genetic in origin because of its high heritability observed in twin and family studies (3, 4), recent evidence supports the involvement of epigenetic regulatory mechanisms in the pathogenesis of ASDs (5–7).”
BackgroundMicroarray data normalization and transformation
Quackenbush, J. (2002) · Nature Genetics · doi:10.1038/ng1032 · Cited by 1,975
INFANTILE AUTISM: A GENETIC STUDY OF 21 TWIN PAIRS
Folstein, S., & Rutter, M. (1977) · Journal of Child Psychology and Psychiatry · doi:10.1111/j.1469-7610.1977.tb00443.x · Cited by 1,361 · cited 1×
“Although autism is largely considered genetic in origin because of its high heritability observed in twin and family studies (3, 4), recent evidence supports the involvement of epigenetic regulatory mechanisms in the pathogenesis of ASDs (5–7).”
BackgroundEpigenetic mechanisms and the transgenerational effects of maternal care
Champagne, F. A. (2008) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2008.03.003 · Cited by 812
Chuang, J. C., & Jones, P. A. (2007) · Pediatric Research · doi:10.1203/pdr.0b013e3180457684 · Cited by 668
Chauhan, A., & Chauhan, V. (2006) · Pathophysiology · doi:10.1016/j.pathophys.2006.05.007 · Cited by 656
Genomic and epigenetic evidence for oxytocin receptor deficiency in autism
Gregory, S. G., Connelly, J. J., Towers, A. J., Johnson, J., Biscocho, D., Markunas, C. A., Lintas, C., Abramson, R. K., Wright, H. H., Ellis, P., et al. (2009) · BMC Medicine · doi:10.1186/1741-7015-7-62 · Cited by 576
Neuropathological findings in autism
Palmen, S. J. M. C. (2004) · Brain · doi:10.1093/brain/awh287 · Cited by 527
Abnormal melatonin synthesis in autism spectrum disorders
Melke, J., Goubran Botros, H., Chaste, P., Betancur, C., Nygren, G., Anckarsäter, H., Rastam, M., Ståhlberg, O., Gillberg, I. C., Delorme, R., et al. (2008) · Molecular Psychiatry · doi:10.1038/sj.mp.4002016 · Cited by 511
Disruption of the nuclear hormone receptor RORα in staggerer mice
Hamilton, B. A., Frankel, W. N., Kerrebrock, A. W., Hawkins, T. L., FitzHugh, W., Kusumi, K., Russell, L. B., Mueller, K. L., van Berkel, V., Birren, B. W., et al. (1996) · Nature · doi:10.1038/379736a0 · Cited by 492
The orphan nuclear receptor RORα regulates circadian transcription of the mammalian core-clock Bmal1
Akashi, M., & Takumi, T. (2005) · Nature Structural & Molecular Biology · doi:10.1038/nsmb925 · Cited by 491
Giguère, V, Tini, M., Flock, G., Ong, E., Evans, R. M., & Otulakowski, G. (1994) · Genes & Development · doi:10.1101/gad.8.5.538 · Cited by 486
Immunity, neuroglia and neuroinflammation in autism
Pardo, C. A., Vargas, D. L., & Zimmerman, A. W. (2005) · International Review of Psychiatry · doi:10.1080/02646830500381930 · Cited by 460
The fragile X mental retardation protein inhibits translation via interacting with mRNA
Li, Z. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.11.2276 · Cited by 447 · cited 1×
“Fragile X syndrome results from an expansion of the trinucleotide CGG repeat in the 5 UTR region of the FMR1 gene, leading to increased susceptibility to methylation and epigenetic silencing of FMR1 (14, 15), and Rett syndrome arises from a mutation in the methyl CpG binding protein 2 (MeCP2) gene, whose protein produ…”
BackgroundField trial for autistic disorder in DSM-IV
(1994) · American Journal of Psychiatry · doi:10.1176/ajp.151.9.1361 · Cited by 401 · cited 1×
“Autism spectrum disorders (ASDs) collectively represent a heterogeneous range of pervasive neurodevelopmental disorders that are characterized by deficits in social interactions and understanding, aberrant communication and/or language development, and restricted interests and stereotyped behaviors (1, 2).”
BackgroundTranslational Suppression by Trinucleotide Repeat Expansion at FMR1
Feng, Y., Zhang, F., Lokey, L. K., Chastain, J. L., Lakkis, L., Eberhart, D., & Warren, S. T. (1995) · Science · doi:10.1126/science.7732383 · Cited by 358 · cited 1×
“Fragile X syndrome results from an expansion of the trinucleotide CGG repeat in the 5 UTR region of the FMR1 gene, leading to increased susceptibility to methylation and epigenetic silencing of FMR1 (14, 15), and Rett syndrome arises from a mutation in the methyl CpG binding protein 2 (MeCP2) gene, whose protein produ…”
BackgroundNagarajan, R., Hogart, A., Gwye, Y., Martin, M. R., & LaSalle, J. M. (2006) · Epigenetics · doi:10.4161/epi.1.4.3514 · Cited by 347 · cited 1×
“To explore the relevance of our findings of enhanced methylation and reduced expression of RORA and BCL-2 in LCLs to the expression of these proteins in the brain, the levels of RORA and BCL-2 protein were investigated in postmortem tissues from autistic subjects and age- and sex-matched controls, using tissue arrays…”
MethodEpigenetics of autism spectrum disorders
Schanen, N. C. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl213 · Cited by 341
Rauch, T., Li, H., Wu, X., & Pfeifer, G. P. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1888 · Cited by 292
Self-citationNishimura, Y., Martin, C. L., Vazquez-Lopez, A., Spence, S. J., Alvarez-Retuerto, A. I., Sigman, M., Steindler, C., Pellegrini, S., Schanen, N. C., Warren, S. T., et al. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm116 · Cited by 276
Immunological Findings in Autism
Cohly, H. H. P., & Panja, A. (2005) · International Review of Neurobiology · doi:10.1016/s0074-7742(05)71013-8 · Cited by 262 · cited 1×
“Bioinformatic analysis of the differentially methylated genes from the CpG island assays (Tables 2 and 3) revealed enrichment for many high-level functions previously implicated in autism, including aberrant response to inflammation (38, 58), decreased cell survival (31), and abnormal cellular differentiation leading…”
BackgroundEnstrom, A. M., Lit, L., Onore, C. E., Gregg, J. P., Hansen, R. L., Pessah, I. N., Hertz-Picciotto, I., Van de Water, J. A., Sharp, F. R., & Ashwood, P. (2009) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2008.08.001 · Cited by 257
Yamashita, S., Tsujino, Y., Moriguchi, K., Tatematsu, M., & Ushijima, T. (2006) · Cancer Science · doi:10.1111/j.1349-7006.2006.00136.x · Cited by 253 · cited 1×
“These primers were previously successful in identifying methylation-specific silencing of RORA in several gastric cancer cell lines (28).”
BackgroundHogart, A., Nagarajan, R. P., Patzel, K. A., Yasui, D. H., & LaSalle, J. M. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm014 · Cited by 233
Toward a developmental neurobiology of autism
Polleux, F., & Lauder, J. M. (2004) · Mental Retardation and Developmental Disabilities Research Reviews · doi:10.1002/mrdd.20044 · Cited by 218
Dysregulation of Reelin and Bcl-2 Proteins in Autistic Cerebellum
Fatemi, S. H., Stary, J. M., Halt, A. R., & Realmuto, G. R. (2001) · Journal of Autism and Developmental Disorders · doi:10.1023/a:1013234708757 · Cited by 212 · cited 4×
“(31) measured levels of BCL-2 in the cerebellar cortex of 5 autistic males and found a 34–51% reduction in levels of BCL-2 protein by Western analyses.”
BackgroundInfluentialComplex disease, gender and epigenetics
Kaminsky, Z., Wang, S., & Petronis, A. (2006) · Annals of Medicine · doi:10.1080/07853890600989211 · Cited by 209 · cited 1×
“56E-02 Neurological disease (12) Delay in cell death of cortical neurons BAK1 5.”
BackgroundHu, V. W., Frank, B. C., Heine, S., Lee, N. H., & Quackenbush, J. (2006) · BMC Genomics · doi:10.1186/1471-2164-7-118 · Cited by 200 · cited 7×
“(18) revealed specific differentially expressed ASD”
BackgroundMethodInfluentialSelf-citationHu, V. W., Sarachana, T., Kim, K. S., Nguyen, A., Kulkarni, S., Steinberg, M. E., Luu, T., Lai, Y., & Lee, N. H. (2009) · Autism Research · doi:10.1002/aur.73 · Cited by 198 · cited 6×
“In addition, these processes reiterate common biological themes in autism that our laboratory has identified from global gene expression profiling of LCLs in discordant monozygotic twins (18), sibling pairs (60), and largescale case-control studies of unrelated subjects (41).”
BackgroundInfluentialSelf-citationThe possible interplay of synaptic and clock genes in autism spectrum disorders
Bourgeron, T. (2007) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2007.72.020 · Cited by 185
Gene expression changes in children with autism
Gregg, J. P., Lit, L., Baron, C. A., Hertz-Picciotto, I., Walker, W., Davis, R. A., Croen, L. A., Ozonoff, S., Hansen, R., Pessah, I. N., et al. (2008) · Genomics · doi:10.1016/j.ygeno.2007.09.003 · Cited by 181
Epigenetic mechanisms in the context of complex diseases
van Vliet, J., Oates, N. A., & Whitelaw, E. (2007) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-6526-z · Cited by 173
Orphan nuclear receptor RORα-deficient mice display the cerebellar defects of staggerer
Dussault, I., Fawcett, D., Matthyssen, A., Bader, J.-A., & Giguère, V. (1998) · Mechanisms of Development · doi:10.1016/s0925-4773(97)00187-1 · Cited by 173
Nicholas, B., Rudrasingham, V, Nash, S., Kirov, G., Owen, M. J., & Wimpory, D. C. (2007) · Molecular Psychiatry · doi:10.1038/sj.mp.4001953 · Cited by 171
Hu, V. W., Nguyen, A., Kim, K. S., Steinberg, M. E., Sarachana, T., Scully, M. A., Soldin, S. J., Luu, T., & Lee, N. H. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005775 · Cited by 158 · cited 1×
“In addition, these processes reiterate common biological themes in autism that our laboratory has identified from global gene expression profiling of LCLs in discordant monozygotic twins (18), sibling pairs (60), and largescale case-control studies of unrelated subjects (41).”
BackgroundSelf-citationGold, D. A., Baek, S. H., Schork, N. J., Rose, D. W., Larsen, D. D., Sachs, B. D., Rosenfeld, M. G., & Hamilton, B. A. (2003) · Neuron · doi:10.1016/s0896-6273(03)00769-4 · Cited by 158
Non‐coding RNAs in the nervous system
Mehler, M. F., & Mattick, J. S. (2006) · The Journal of Physiology · doi:10.1113/jphysiol.2006.113191 · Cited by 154
Neuropathological and Genetic Findings in Autism: The Significance of a Putative Minicolumnopathy
Casanova, M. F. (2006) · The Neuroscientist · doi:10.1177/1073858406290375 · Cited by 109 · cited 1×
“Bioinformatic analysis of the differentially methylated genes from the CpG island assays (Tables 2 and 3) revealed enrichment for many high-level functions previously implicated in autism, including aberrant response to inflammation (38, 58), decreased cell survival (31), and abnormal cellular differentiation leading…”
BackgroundRORα in genetic control of cerebellum development: 50 staggering years
Gold, D. A., Gent, P. M., & Hamilton, B. A. (2006) · Brain Research · doi:10.1016/j.brainres.2005.11.080 · Cited by 106
Boukhtouche, F., Vodjdani, G., Jarvis, C. I., Bakouche, J., Staels, B., Mallet, J., Mariani, J., Lemaigre‐Dubreuil, Y., & Brugg, B. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03708.x · Cited by 106
Autism: highly heritable but not inherited
Beaudet, A. L. (2007) · Nature Medicine · doi:10.1038/nm0507-534 · Cited by 100
Jarvis, C. I., Staels, B., Brugg, B., Lemaigre‐Dubreuil, Y., Tedgui, A., & Mariani, J. (2002) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(01)00668-2 · Cited by 84
Doulazmi, M., Fr�d�ric, F., Lemaigre-Dubreuil, Y., Hadj-Sahraoui, N., Delhaye-Bouchaud, N., & Mariani, J. (1999) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19990823)411:2<267::aid-cne7>3.0.co;2-4 · Cited by 81
Fatemi, S. H., & Halt, A. R. (2001) · Synapse · doi:10.1002/syn.10002 · Cited by 79
Boukhtouche, F., Doulazmi, M., Frédéric, F., Dusart, I., Brugg, B., & Mariani, J. (2006) · The Cerebellum · doi:10.1080/14734220600750184 · Cited by 74
Utilization of Lymphoblastoid Cell Lines as a System for the Molecular Modeling of Autism
Baron, C. A., Liu, S. Y., Hicks, C., & Gregg, J. P. (2006) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-006-0134-x · Cited by 69
Imprinted genes and mental dysfunction
Davies, W., Isles, A. R., & Wilkinson, L. S. (2001) · Annals of Medicine · doi:10.3109/07853890108995956 · Cited by 68
Methyl‐CpG‐binding protein 2 polymorphisms and vulnerability to autism
Loat, C. S., Curran, S., Lewis, C. M., Duvall, J., Geschwind, D., Bolton, P., & Craig, I. W. (2008) · Genes, Brain and Behavior · doi:10.1111/j.1601-183x.2008.00414.x · Cited by 64
Exploration and Spatial Learning In Staggerer Mutant Mice
Lalonde, R. (1987) · Journal of Neurogenetics · doi:10.3109/01677068709102349 · Cited by 63
Hadj‐Sahraoui, N., Frédéric, F., Zanjani, H., Delhaye‐Bouchaud, N., Herrup, K., & Mariani, J. (2001) · Developmental Brain Research · doi:10.1016/s0165-3806(01)00095-5 · Cited by 60
Spontaneous alternation and exploration in weaver mutant mice
Lalonde, R., Manseau, M., & Botez, M. I. (1988) · Behavioural Brain Research · doi:10.1016/0166-4328(88)90013-7 · Cited by 47
Mutations in the gene encoding methyl-CpG-binding protein 2 cause Rett syndrome
Van den Veyver, I. B., & Zoghbi, H. Y. (2001) · Brain and Development · doi:10.1016/s0387-7604(01)00376-x · Cited by 46 · cited 1×
“Fragile X syndrome results from an expansion of the trinucleotide CGG repeat in the 5 UTR region of the FMR1 gene, leading to increased susceptibility to methylation and epigenetic silencing of FMR1 (14, 15), and Rett syndrome arises from a mutation in the methyl CpG binding protein 2 (MeCP2) gene, whose protein produ…”
BackgroundEpigenetic and Pharmacoepigenomic Studies of Major Psychoses and Potentials for Therapeutics
Abdolmaleky, H. M., Zhou, J.-R., Thiagalingam, S., & Smith, C. L. (2008) · Pharmacogenomics · doi:10.2217/14622416.9.12.1809 · Cited by 45 · cited 1×
“This ability to translate findings from peripheral tissues to the brain is consistent with reports of individuals with neuropsychiatric disorders having detectable epigenetic programming disturbances, both in the brain and in secondary tissues (61).”
ResultSpontaneous alternation and exploration in staggerer mutant mice
Lalonde, R., Manseau, M., & Botez, M. I. (1988) · Behavioural Brain Research · doi:10.1016/0166-4328(88)90124-6 · Cited by 42
Lopez‐Rangel, E., & Lewis, M. E. S. (2005) · Clinical Genetics · doi:10.1111/j.1399-0004.2006.00543a.x · Cited by 37
Giguère, V., Beatty, B., Squire, J. A., Copeland, N. G., & Jenkins, N. A. (1995) · Genomics · doi:10.1006/geno.1995.1197 · Cited by 37
Hamilton, B. A., Frankel, W. N., Kerrebrock, A. W., Hawkins, T. L., Fitzhugh, W. W., Kusumi, K., Russell, L. B., Mueller, K. L., van Berkel, V. H., Birren, B. W., et al. (1996) · Nature · Cited by 33
Object exploration in staggerer mutant mice
Lalonde, R., Botez, M. I., & Boivin, D. B. (1987) · Physiology & Behavior · doi:10.1016/0031-9384(87)90139-9 · Cited by 24
Discrimination learning in Rorasg and Grid2 mutant mice
Lalonde, R., & Strazielle, C. (2008) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2008.05.004 · Cited by 21
Abnormal patterns of maze patrolling in the mutant mouse staggerer
Goodall, G., & Gheusi, G. (1987) · Behavioral and Neural Biology · doi:10.1016/s0163-1047(87)90422-5 · Cited by 20 · cited 1×
“Although there are few descriptions of behavioral phenotypes of RORA-knockout or staggerer mice, there is some evidence that RORA-deficient animals exhibit autistic-like restricted behaviors such as limited maze patrolling (52), anomalous spatial learning, reduced exploration, and perseverative behavior in comparison…”
BackgroundToward DSM-IV: A Developmental Approach to Autistic Disorder
Siegel, B. (1991) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(18)30324-1 · Cited by 20 · cited 1×
“Autism spectrum disorders (ASDs) collectively represent a heterogeneous range of pervasive neurodevelopmental disorders that are characterized by deficits in social interactions and understanding, aberrant communication and/or language development, and restricted interests and stereotyped behaviors (1, 2).”
BackgroundEberhart, C. G., Copeland, J. A., & Abel, T. W. (2006) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-006-0135-9 · Cited by 8 · cited 2×
“Charles Eberhart (Johns Hopkins Pathology Department Tissue Microarray Core Facility, Baltimore, MD, USA), as described previously (29).”
BackgroundMethod[Genetics and epigenetics in autism].
Nakayama, A., Masaki, S., & Aoki, E. (2006) · PubMed · Cited by 5
Research works printed but not linked: 1
- 10.4161/epi.1.4.3514 · DOI · Paper page
Cited by
Sex differences in autism spectrum disorders
Werling, D. M., & Geschwind, D. H. (2013) · Current Opinion in Neurology · doi:10.1097/wco.0b013e32835ee548 · Cited by 1,245
Epigenome-wide association studies for common human diseases
Rakyan, V. K., Down, T. A., Balding, D. J., & Beck, S. (2011) · Nature Reviews Genetics · doi:10.1038/nrg3000 · Cited by 1,267
Reinius, L. E., Acevedo, N., Joerink, M., Pershagen, G., Dahlén, S.-E., Greco, D., Söderhäll, C., Scheynius, A., & Kere, J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041361 · Cited by 1,035
“polymorphisms depending on parent-of-origin [14], DNA methylation differences in disease-discordant monozygotic twins [15,16,17], differences in DNA methylation related to environmental exposures [18,19], and DNA methylation differences in affected versus non-affected tissues [20,21].”
BackgroundAutism risk factors: genes, environment, and gene-environment interactions
Chaste, P., & Leboyer, M. (2012) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2012.14.3/pchaste · Cited by 807
Why are autism spectrum conditions more prevalent in males?
Baron-Cohen, S., Lombardo, M. V., Auyeung, B., Ashwin, E., Chakrabarti, B., & Knickmeyer, R. (2011) · PLoS Biology · doi:10.1371/journal.pbio.1001081 · Cited by 754
“Decreased expression of RORA gene and aromatase in post-mortem frontal and cerebellar tissue [179,180]”
Background
Metadata
- Authors
- Nguyen, A., Rauch, T. A., Pfeifer, G. P., & Hu, V. W.
- Affiliations
- George Washington University (US)
- City Of Hope National Medical Center (US)
- Corresponding author
- Hu, Valerie W.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2010-04-07
- Volume
- 24
- Issue
- 8
- Pages
- 3036-3051
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- PMC
- PMC2909294
- OpenAlex
- W2165836069
- Cited by
- 350
- References
- 68
- Citations by year
- 2026: 4 · 2025: 12 · 2024: 12 · 2023: 18 · 2022: 17 · 2021: 14 · 2020: 22 · 2019: 23 · 2018: 21 · 2017: 22 · 2016: 27 · 2015: 29 · 2014: 30 · 2013: 34 · 2012: 30
- FWCI
- 19.15
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- The FASEB Journal (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Autism Speaks (2381)
- National Institutes of Health (R21 MH073393)
- National Institute of Mental Health (1U24MH081810)
- Topics
- Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Keywords
- autism spectrum disorder, DNA methylation, epigenetic regulation, RORA, Bcl-2, monozygotic twin discordance, lymphoblastoid cell lines, CpG island methylation, autism candidate genes, cerebellum, frontal cortex
- MeSH terms
- Brain Chemistry, Cell Line, Child, Child Development Disorders, Pervasive, Humans, Lymphocytes, Male, DNA Methylation, Genetic Predisposition to Disease, Epigenesis, Genetic, Nuclear Receptor Subfamily 1, Group F, Member 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.